J&J says single dose protects against breakthrough COVID-19 for up to six months
The study, sponsored by the vaccine developer, was conducted between 1st January and 7th September last year, before the Omicron…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
MSN to launch generic anti-COVID pill Molnupiravir under ‘Molulow’ brand
Molulow will come as a pack of 4×10 capsule strips with each capsule in 200 mg strength
Gavi and Bharat Biotech discuss possible COVAX use of Covaxin
About 180 million Covaxin doses have been administered in India and more than three million doses have been exported or donated
Lupin launches Molnupiravir under brand name Molnulup to treat COVID-19
Clinical data suggests that it is effective on patients with co-morbidities
Yokogawa enters into capital and business alliance with GlyTech
The partnership is to build biosynthesis processes and a pharmaceutical production platform
Preparing for 2022: Lessons and Strategies
As we enter into a new year, pharma industry’s stakeholders talk about various strategies to implement the lessons learnt from the…
Maharashtra health minister inaugurates BSV R&D centre at Airoli
The R&D centre will endeavour to bring scientifically-advanced biological, biotechnology products and novel drug delivery…
Alembic Pharmaceuticals receives US FDA tentative approval for Vortioxetine tablets
The tablets are indicated for the treatment of Major Depressive Disorder (MDD)
Pharma industry reports 66 deals worth $26.1 billion in December 2021: GlobalData
The industry reported 117 venture capital (VC) deals worth $3.8 billion in December 2021, compared to the last 12-month average of…
Alembic Pharmaceuticals receives USFDA final approval for Entacapone tablets
The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Comtan tablets, 200 mg, of Orion…